Gliknik is a privately held biopharmaceutical company working to ease human suffering by creating new therapies for people living with immune disorders. The company has two novel drugs in clinical trials and others being advanced preclinically.

Gliknik is a privately held biopharmaceutical company working to ease human suffering by creating new therapies for people living with immune disorders. The company has two novel drugs in clinical trials and others being advanced preclinically.